NL-OMON25485
Completed
Not Applicable
Tolerance and safety study of a new paediatric peptide feed.
umico Research B.V.0 sites24 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- umico Research B.V.
- Enrollment
- 24
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
/A
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Children requiring a paediatric peptide feed. Some conditions where this is required may include inflammatory bowel disease, short bowel syndrome, pancreas/liver disease, chronic diarrhoea, cystic fibrosis, undiagnosed gut problems, coeliac disease;
- •2\. Approximately 8\-30 kg in weight;
Exclusion Criteria
- •1\. Unsuitable for infants under 1 year of age;
- •2\. Children receiving parenteral nutrition for more than 50% energy requirements;
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Tolerance and safety study of a new paediatric peptide feedISRCTN48462333umico Research B.V. (Netherlands)24
Completed
Not Applicable
Acceptability study of a new paediatric formulation of Orphacol® (cholic acid) in paediatric patients treated for inborn errors in primary bile acid synthesis due to 3ß-Hydroxy-?5-C27- steroid oxidoreductase deficiency or ?4-3-Oxosteroid-5ß-reductase deficiency.K76.8Other specified diseases of liverDRKS00013645aboratoires CTRS4
Active, not recruiting
Phase 1
Acceptability study of a new paediatric form of vigabatrin in infants and children with infantile spasms or pharmaco-resistant partial epilepsy.Infantile spasms and pharmaco-resistant partial epilepsyMedDRA version: 18.0Level: PTClassification code 10021750Term: Infantile spasmsSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 18.0Level: LLTClassification code 10065336Term: Partial epilepsySystem Organ Class: 10029205 - Nervous system disordersTherapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2014-000360-17-FRTARGEO
Recruiting
Phase 2
First in patients of a New PET Probe FEDACMalignant tumors(solid tumors)JPRN-jRCTs031220192Tamura Kentaro30
Completed
Not Applicable
First in Human study of a New PET Probe FEDACJPRN-jRCTs031210134Tamura Kentaro10